Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein substrates with small hydrophobic P1 residues is a classification used to describe the specificity of certain proteases rather than a single molecular target. In the Schechter and Berger nomenclature, the P1 residue is the amino acid on the amino-terminal side of the peptide bond that is cleaved (Schechter & Berger, 1967). Proteases such as neutrophil elastase and pancreatic elastase specifically recognize and cleave peptide bonds where the P1 position is occupied by small hydrophobic residues like alanine or valine (Bieth, 1986). These substrates include structural proteins like elastin and various signaling molecules involved in the inflammatory response. Because this term encompasses a wide variety of proteins sharing a common cleavage motif, it does not represent a discrete therapeutic target for drug development. Instead, therapeutic interventions are directed at the enzymes (e.g., elastases) that act upon these substrates to prevent excessive tissue degradation in diseases such as COPD and cystic fibrosis (Rawlings et al., 2018).
Not applicable; this is a substrate specificity profile, not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein substrates with small hydrophobic P1 residues.